BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 21486431)

  • 1. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
    Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
    BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy.
    Huang TL; Tsai WL; Chien CY; Lee TF; Fang FM
    Qual Life Res; 2010 Nov; 19(9):1243-54. PubMed ID: 20544291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
    Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
    J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain?
    Tribius S; Bergelt C
    Cancer Treat Rev; 2011 Nov; 37(7):511-9. PubMed ID: 21324605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
    Parkar S; Sharma A; Shah M
    J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
    Bian X; Song T; Wu S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
    Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM
    PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explorative study on quality of life in relation to salivary secretion rate in patients with head and neck cancer treated with radiotherapy.
    Almståhl A; Alstad T; Fagerberg-Mohlin B; Carlén A; Finizia C
    Head Neck; 2016 May; 38(5):782-91. PubMed ID: 25537660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer.
    Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M
    Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
    Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy.
    Fang FM; Chien CY; Kuo SC; Chiu HC; Wang CJ
    Acta Oncol; 2004; 43(6):571-8. PubMed ID: 15370615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
    Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
    Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosticators and the relationship of depression and quality of life in head and neck cancer.
    Chiou WY; Lee MS; Ho HC; Hung SK; Lin HY; Su YC; Lee CC
    Indian J Cancer; 2013; 50(1):14-20. PubMed ID: 23713039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
    Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
    Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Taylor KJ; Amdal CD; Bjordal K; Astrup GL; Herlofson BB; Duprez F; Gama RR; Jacinto A; Hammerlid E; Scricciolo M; Jansen F; Verdonck-de Leeuw IM; Fanetti G; Guntinas-Lichius O; Inhestern J; Dragan T; Fabian A; Boehm A; Wöhner U; Kiyota N; Krüger M; Bonomo P; Pinto M; Nuyts S; Silva JC; Stromberger C; Specenier P; Tramacere F; Bushnak A; Perotti P; Plath M; Paderno A; Stempler N; Kouri M; Grégoire V; Singer S;
    Int J Cancer; 2024 May; 154(10):1772-1785. PubMed ID: 38312044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT.
    Yuce Sari S; Yazici G; Yuce D; Karabulut E; Cengiz M; Ozyigit G
    Clin Nutr ESPEN; 2016 Dec; 16():30-35. PubMed ID: 28531452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
    Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
    Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.